10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549   

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2019

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From ________ to _________

Commission File Number 000-50009

PACIFIC HEALTH CARE ORGANIZATION, INC.
(Exact name of registrant as specified in its charter)
Utah	87-0285238
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer I.D. No.)
1201 Dove Street, Suite 300
Newport Beach, California	92660
(Address of principal executive offices)	(Zip Code)

(949) 721-8272

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act :

Title of each class	Trading Symbol	Name of each exchange on which registered
None	N/A	N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for any shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒   No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.)   Yes ☒   No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer (Do not check if a smaller reporting company) ☐	Smaller reporting company ☒
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)     Yes ☐    No ☒

As of May 20, 2019, the registrant had 3,200,000 shares of common stock, par value $0.001, issued and outstanding.

PACIFIC HEALTH CARE ORGANIZATION, INC.

FORM 10-Q

TABLE OF CONTENTS 

		Page
PART I — FINANCIAL INFORMATION
Item 1.  Condensed Consolidated Financial Statements		3
	(Unaudited) Balance Sheets as of March 31, 2019 and December 31, 2018	3
	(Unaudited) Statements of Operations for the Three Months Ended March 31, 2019 and 2018	4
	(Unaudited) Statement of Stockholders’ Equity for the Three Months Ended March 31, 2019 and 2018	5
	(Unaudited) Statements of Cash Flows for the Three Months Ended March 31, 2019 and 2018	6
	Notes to Condensed Consolidated Financial Statements (Unaudited)	7
Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations		10
Item 3.  Quantitative and Qualitative Disclosure about Market Risk		16
Item 4.  Controls and Procedures		16
PART II — OTHER INFORMATION
Item 1A.  Risk Factors		17
Item 6.  Exhibits		17
Signatures		18

PART I.   FINANCIAL INFORMATION

Item 1.     Financial Information

Pacific Health Care Organization, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

ASSETS
	March 31,			December31,
	2019			2018
Current Assets
Cash	$	7,368,174		$	7,072,507
Accounts receivable, net of allowance of $28,442 and $28,442		1,100,867			940,426
Deferred tax assets		63,465			63,465
Prepaid income tax		73,959			73,959
Receivable – Other		23,715			23,715
Prepaid expenses		186,545			163,255
Total current assets		8,816,725			8,337,327
Property and Equipment, net
Computer equipment		407,503			405,219
Furniture and fixtures		215,960			215,960
Office equipment		9,556			9,556
Total property and equipment		633,019			630,735
Less: accumulated depreciation and amortization		(507,992	)		(489,108	)
Net property and equipment		125,027			141,627
Operating lease right-of-use asset, net		719,861			-
Other assets		26,788			26,788
Total assets	$	9,688,401		$	8,505,742
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Accounts payable	$	70,672		$	63,724
Accrued expenses		272,092			248,455
Credit card payable		1,444			3,146
Income tax payable		122,859			100
Deferred rent expense		22,707			26,114
Dividend payable		37,000			37,000
Operating lease liabilities, current portion		247,472			-
Unearned revenue		45,448			45,448
Total current liabilities		819,694			423,987
Long Term Liabilities
Operating lease liabilities, long-term portion		472,389			-
Total Liabilities		1,292,083			423,987
Commitments and Contingencies		-			-
Stockholders’ Equity
Preferred stock; 5,000,000 shares authorized at $0.001 par value of which 10,000 shares designated as Series A preferred and 4,000 shares issued and outstanding at March 31, 2019 and December 31, 2018		4			4
Common stock, $0.001 par value, 200,000,000 shares authorized, 3,200,000 shares issued and outstanding at March 31, 2019 and December 31, 2018		3,200			3,200
Additional paid-in capital		425,669			425,669
Retained earnings		7,967,445			7,652,882
Total stockholders’ equity		8,396,318			8,081,755
Total liabilities and stockholders’ equity	$	9,688,401		$	8,505,742

 The accompanying notes are an integral part of these condensed consolidated financial statements. 

3

Pacific Health Care Organization, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

	For three months ended March 31,
	2019			2018
Revenues:
HCO fees	$	370,342		$	399,442
MPN fees		123,865			134,644
Utilization review		292,683			287,021
Medical bill review		134,997			114,039
Medical case management		781,614			582,569
Other		79,937			65,594
Total revenues		1,783,438			1,583,309
Expenses:
Depreciation and amortization		18,884			16,344
Consulting fees		79,635			78,814
Salaries and wages		753,705			491,478
Professional fees		77,965			77,470
Insurance		73,383			67,029
Outsource service fees		124,809			95,881
Data maintenance		10,300			32,431
General and administrative		207,435			168,205
Total expenses		1,346,116			1,027,652
Income from operations		437,322			555,657
Other expense
Interest expense		-			-
Total other expense		-			-
Income before income tax provision		437,322			555,657
Income tax provision		(122,759	)		(155,976	)
Net income	$	314,563		$	399,681
Basic and fully diluted earnings per share:
Earnings per share amount	$	0.10		$	0.12
Weighted average common shares outstanding		3,200,000			3,200,000
Fully diluted earnings per share:
Earnings per share amount	$	0.09		$	0.11
Fully diluted common shares outstanding		3,544,000			3,544,000

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

Pacific Health Care Organization, Inc.

Condensed Consolidated Statements of Stockholders' Equity

(Unaudited)

	Preferred Stock		Common Stock		Additional paid-in capital		Retained earnings		Total stockholder’s equity
Balances at December 31, 2017	$	4	$	3,200	$	425,669	$	6,293,105	$	6,721,978
Net Income						-		399,681		399,681
Balances at March 31, 2018	$	4	$	3,200	$	425,669	$	6,692,786	$	7,121,659
Balances at December 31, 2018	$	4	$	3,200	$	425,669	$	7,652,882	$	8,081,755
Net Income						-		314,563		314,563
Balances at March 31, 2019	$	4	$	3,200	$	425,669	$	7,967,445	$	8,396,318

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

Pacific Health Care Organization, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Three Months Ended March 31,
	2019			2018
Cash flows from operating activities:
Net income	$	314,563		$	399,681
Adjustments to reconcile net income to net cash:
Depreciation and amortization		18,884			16,344
Changes in operating assets and liabilities
(Increase) decrease in accounts receivable		(160,441	)		377,919
(Increase) in prepaid expenses		(23,290	)		(3,875	)
Increase (decrease) in accounts payable		6,948			(47,225	)
(Decrease) in deferred rent expense		(3,407	)		(1,142	)
(Decrease) in credit card payables		(1,702	)		-
Increase (decrease) in accrued expenses		23,637			(4,412	)
Increase in income tax payable		122,759			155,976
Decrease in unearned revenue		-			332
Net cash provided in operating activities		297,951			893,598
Cash flows from investing activities:
Purchase of furniture and office equipment		(2,284	)		(2,988	)
Net cash used in investing activities		(2,284	)		(2,988	)
Cash flows from financing activities:
Net cash used in financing activities		-			-
Increase in cash		295,667			890,610
Cash at beginning of period		7,072,507			5,815,071
Cash at end of period	$	7,368,174		$	6,705,681
Supplemental cash flow information
Cash paid for:
Interest	$	-		$	-
Income taxes paid	$	-		$	-
Non-cash investing and financing activities
Initial recognition of operating lease right of use asset and operating lease liabilities	$	719,861		$	-

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

Pacific Health Care Organization, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2019

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”) and in accordance with accounting principles generally accepted in the United States (“GAAP”).  Certain information and footnote disclosures normally included in consolidated financial statements have been condensed or omitted in accordance with GAAP rules and regulations.  The information furnished in these interim condensed consolidated financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect both the recorded values of assets and liabilities at the date of the condensed consolidated financial statements and the revenues recognized and expenses incurred during the reporting period. These estimates and assumptions affect the Company’s recognition of deferred expenses, bad debts, income taxes, the carrying value of its long-lived assets and its provision for certain contingencies. The reasonableness of these estimates and assumptions is evaluated continually based on a combination of historical information and other information that comes to the Company’s attention that may vary its outlook for the future. While management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed consolidated financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its annual report on Form 10-K for the year ended December 31, 2018.  Operating results for the three months ended March 31, 2019, are not necessarily indicative of the results to be expected for the year ending December 31, 2019.

Principles of Consolidation — The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  Intercompany transactions and balances have been eliminated in consolidation.

Basis of Accounting — The Company uses the accrual method of accounting.

Revenue Recognition — The Company follows the guidance of Accounting Standards Codification (ASC) 606, “Revenue from Contracts with Customers (Topic 606).”

Topic 606 creates a five-step model to recognize revenue which includes (i) identifying the contract with the customer, (ii) identifying the performance obligations in the contract, (iii) determining the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocating the transaction price to the respective performance obligations in the contract, and (v) recognizing revenue when (or as) the Company satisfies the performance obligation. 

The Company derives its revenue from the sale of managed care, bill review, utilization review and medical case management services. These services are billed individually as separate components to our customers. These fees include monthly administration fees, claim network fees, legal support fees, Medicare set-aside fees, lien service fees, workers’ compensation carve-outs, flat rate fees or hourly fees depending on the agreement with the client.

The Company enters into arrangements for bundled managed care which includes various units of accounting such as network solutions and patient management, including managed care. Such elements are considered separate units of accounting due to each element having value to the customer on a stand-alone basis and are billed separately. The selling price for each unit of accounting is determined using the contract price. When the Company’s customers purchase several products the pricing of the products sold is generally the same as if the products were sold on an individual basis. Revenue is recognized as the work is performed in accordance with the Company’s customer contracts. Based upon the nature of the Company’s products, bundled managed care elements are generally delivered in the same accounting period. The Company recognizes revenue for patient management services ratably over the life of the customer contract. Based upon prior experience in managed care, the Company estimates the deferral amount from when the customer’s claim is received to when the customer contract expires. Advance payments from subscribers and billings made in advance are recorded on the balance sheet as deferred revenue.

7

Accounts Receivables and Bad Debt Allowance – In the normal course of business the Company extends credit to its customers on a short-term basis.  Although the credit risk associated with these customers is minimal, the Company routinely reviews its accounts receivable balances and makes provisions for doubtful accounts.  The Company ages its receivables by date of invoice.  Management reviews bad debt reserves quarterly and reserves specific accounts as warranted or sets up a general reserve based on amounts over 90 days past due.  When an account is deemed uncollectible, the Company charges off the receivable against the bad debt reserve.  A considerable amount of judgment is required in assessing the realization of these receivables including the current creditworthiness of each customer and related aging of the past-due balances, including any billing disputes.  In order to assess the collectability of these receivables, the Company performs ongoing credit evaluations of its customers’ financial condition. Through these evaluations, the Company may become aware of a situation where a customer may not be able to meet its financial obligations due to deterioration of its financial viability, credit rating or bankruptcy.  The allowance for doubtful accounts is based on the best information available to the Company and is reevaluated and adjusted as additional information is received.  We evaluate the allowance based on historical write-off experience, the size of the individual customer balances, past-due amounts and the overall national economy.  At March 31, 2019 and December 31, 2018, bad debt reserves of $28,442 and $28,442, respectively, was a general reserve for certain balances over 90 days past due and for accounts that are potentially uncollectible.

The percentages of the amounts due from major customers to total accounts receivable as of March 31, 2019 and December 31, 2018, are as follows:

	3/31/2019			12/31/2018
Customer A		31	%		27	%
Customer B		3	%		10	%
Customer C		10	%		9	%

Significant Customers - We provide services to insurers, third party administrators, self-administered employers, municipalities and other industries.  We are able to provide our full range of services to virtually any size employer in the state of California.  We are also able to provide utilization review, medical bill review and medical case management services outside the state of California. 

During the period ended March 31, 2019 and 2018, we had three customers that accounted for more than 10% of our total sales.  The following table sets forth details regarding the percentage of total sales attributable to our significant customers in the past two years:

	3/31/2019			3/31/2018
Customer A		28	%		32	%
Customer B		13	%		11	%
Customer C		10	%		6	%

Leases - Prior to January 1, 2019, the Company accounted for leases under ASC 840, Accounting for Leases. Effective January 1, 2019, the Company adopted the guidance of ASC 842, Leases, which requires an entity to recognize a right-of-use asset and a lease liability for virtually all leases. The Company adopted ASC 842 using a modified retrospective approach. As a result, the comparative financial information has not been updated and the required disclosures prior to the date of adoption have not been updated and continue to be reported under the accounting standards in effect for those periods. The adoption of ASC 842 on January 1, 2019 resulted in the recognition of operating lease right-of-use assets of $719,861, lease liabilities for operating leases of $719,861, and a zero cumulative-effect adjustment to accumulated deficit. The Company elected to exclude from its balance sheets recognition of leases having a term of 12 months or less (“short-term leases”). Lease expense is recognized on a straight-line basis over the lease term. See Note 2 for further information regarding the impact of the adoption of ASC 842 on the Company’s financial statements.

NOTE 2- OPERATING LEASES

In July 2015, the Company entered a 79-month lease to lease approximately 9,439 square feet of office space that commenced in September 2015. This office space serves as the Company’s principal executive offices, as well as, the principal offices of our operating subsidiaries. In March 2017, the Company entered a 39-month operating lease for an office copy machine with scanner with monthly payment at $1,723, commencing in April 2017.

8

Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Generally the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The operating lease ROU asset includes any lease payments made and excludes lease incentives.

The components of lease expense and supplemental cash flow information related to leases for the period are as follows:

	Three Months Ended March 31, 2019
Lease Cost
Operating lease cost (included in general and administrative in the Company’s condensed consolidated statement of operations)	$	66,230
Other Information
Cash paid for amounts included in the measurement of lease liabilities for the first quarter 2019	$	66,230
Weighted average remaining lease term – operating leases (in years)	3 years
Average discount rate – operating leases		5.75	%

The supplemental balance sheet information related to leases for the period is as follows:

	At March 31, 2019
Operating leases
Long-term right-of-use assets	$	719,861
Short-term operating lease liabilities	$	247,472
Long-term operating lease liabilities		472,389
Total operating lease liabilities	$	719,861

Maturities of the Company’s lease liabilities are as follows:

Year Ending	Operating Leases
2019 (remaining 9 months)	$	191,449
2020		281,803
2021		257,024
2022		71,359
Total lease payments		801,635
Less: Imputed interest/present value discount		(81,774	)
Present value of lease liabilities	$	719,861

Lease expenses were $66,230 and $66,230 during the three months ended March 31, 2019 and 2018, respectively.

NOTE 3 - SUBSEQUENT EVENTS

In accordance with ASC 855-10 Company management reviewed all material events through the date of issuance and there are no material subsequent events to report.

9

Item 2.     Management’s Discussion and Analysis of Financial Statements and Results of Operations

This quarterly report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are based on management’s beliefs and assumptions and on information currently available to them.  For this purpose, any statement contained in this report that is not a statement of historical fact may be deemed to be forward-looking, including statements about our revenue, spending, cash flow, products, new customer acquisitions, trends, actions, intentions, plans, strategies and objectives.  Without limiting the foregoing, words such as “may,” “hope,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “project,” “intend,” “budget,” “plan,” “forecast,” “predict,” “could,” “should,” or “continue” or comparable terminology are intended to identify forward-looking statements.  These statements by their nature involve substantial risks and uncertainty, and actual results may differ materially depending on a variety of factors, many of which are not within our control.  These factors include but are not limited to economic conditions generally and in the industry in which we and our customers participate; cost reduction efforts by our existing and prospective customers; competition within our industry, including competition from much larger competitors; business combinations; legislative requirements or changes which could render our services less competitive or obsolete; our failure to successfully develop new services and/or products or to anticipate current or prospective customers’ needs; our ability to retain existing customers and to attract new customers; price increases; employee limitations; and delays, reductions, or cancellations of contracts we have previously entered.

Forward-looking statements are predictions and not guarantees of future performance or events.  Forward-looking statements are based on current industry, financial and economic information, which we have assessed but which, by its nature, is dynamic and subject to rapid and possibly abrupt changes.  Our actual results could differ materially from those stated or implied by such forward-looking statements due to risks and uncertainties associated with our business.  We hereby qualify all our forward-looking statements by these cautionary statements. These forward-looking statements speak only as of their dates and should not be relied upon.  We undertake no obligation to publicly update or revise any forward-looking statements whether as a result of new information, future events or otherwise (other than pursuant to reporting obligations imposed on registrants pursuant to the Exchange Act) to reflect subsequent events or circumstances.

The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes contained elsewhere in this report and in our other filings with the Commission.

Throughout this quarterly report on Form 10-Q, unless the context indicates otherwise, the terms, “we,” “us,” “our” or “the Company” refer to Pacific Health Care Organization, Inc., (“PHCO”) and our wholly-owned subsidiaries Medex Healthcare, Inc. (“Medex”), Industrial Resolutions Coalition, Inc. (“IRC”), Medex Managed Care, Inc. (“MMC”), Medex Medical Management, Inc. (“MMM”), Medex Legal Support, Inc., (“MLS”) and Pacific Medical Holding Company, Inc. (“PMHC”).

Overview

We are a specialty workers’ compensation managed care company providing a range of services principally to California employers and claims administrators.  We incorporated under the laws of the state of Utah in April 1970, under the name Clear Air, Inc.  We changed our name to Pacific Health Care Organization, Inc., in January 2001.  In February 2001, we acquired Medex Healthcare, Inc. (“Medex”), a California corporation organized in March 1994, in a share for share exchange.  Medex is in the business of managing and administering both Health Care Organizations (“HCOs”) and Managed Provider Networks (“MPNs”) in the state of California.  In August 2001, we formed Industrial Resolutions Coalition, Inc. (“IRC”), a California corporation, as a wholly-owned subsidiary of PHCO.  IRC oversees and manages the Company’s Workers’ Compensation Carve-Outs services. In June 2010, we acquired Medex Legal Support, Inc. (“MLS”), a Nevada corporation incorporated in September 2009.  MLS offers lien representation services and Medicare Set Aside (“MSA”) services.  In February 2012, we incorporated Medex Medical Management, Inc., (“MMM”) in the state of Nevada, as a wholly owned subsidiary of the Company.  MMM is responsible for overseeing and managing medical case management services. In March 2011, we incorporated Medex Managed Care, Inc. (“MMC”) in the state of Nevada, as a wholly owned subsidiary of the Company.  MMC oversees and manages the Company’s utilization review and managed bill review services. In October 2018, we incorporated Pacific Medical Holding Company, Inc. (“PMHC”) to act as a holding company for future potential acquisitions.

 Our clients include self-administered employers, insurers, third party administrators, municipalities and others. Our principal clients are in the State of California where the high cost of workers’ compensation insurance is a critical problem for employers.  We have processed medical bill reviews in 25 states. Our provider networks are composed of experts in treating worker injuries. 

10

Business of the Company

We are workers’ compensation cost containment specialists.  Our business objective is to deliver value to our clients that reduces their workers’ compensation related medical claims expense in a manner that will assure that injured employees receive high quality healthcare that allows them to recover from injury and return to gainful employment without undue delay.  According to studies conducted by auditing bodies on behalf of the California Division of Workers’ Compensation, (“DWC”) the two most significant cost drivers for workers’ compensation are claims frequency and medical treatment costs.

Results of Operations

The following represents selected components of our consolidated results of operations, for the three-month period ended March 31, 2019 and 2018, respectively, together with changes from period-to-period:

	For three months ended March 31,
	2019			2018			Amount Change			% Change
Revenues:
HCO	$	370,342		$	399,442		$	(29,100	)		(7	%)
MPN		123,865			134,644			(10,779	)		(8	%)
Utilization review		292,683			287,021			5,662			2	%
Medical bill review		134,997			114,039			20,958			18	%
Medical case management		781,614			582,569			199,045			34	%
Other		79,937			65,594			14,343			22	%
Total revenues		1,783,438			1,583,309			200,129			13	%
Expense:
Depreciation and amortization		18,884			16,344			2,540			16	%
Consulting fees		79,635			78,814			822			1	%
Salaries and wages		753,705			491,478			262,227			53	%
Professional fees		77,965			77,470			495			1	%
Insurance		73,383			67,029			6,354			9	%
Outsource service fees		124,809			95,881			28,928			30	%
Data maintenance		10,300			32,431			(22,131	)		(68	%)
General and administrative		207,435			168,205			39,230			23	%
Total expenses		1,346,116			1,027,652			318,465			31	%
Income from operations		437,322			555,657			(118,336	)		(21	%)
Other expense
Interest expense		-			-			-			-	%
Total other expense		-			-			-			-	%
Income before income tax provision		437,322			555,657			(118,336	)		(21	%)
Income tax provision		(122,759	)		(155,976	)		(33,217	)		(21	%)
Net income	$	314,563		$	399,681		$	(85,119	)		(21	%)

Revenue

Total revenues during the three-month period ended March 31, 2019, increased 13% to $1,783,438 compared to $1,583,309 during the three-month period ended March 31, 2018.

During the first quarter 2019, utilization review, medical bill review, medical case management, and other revenues increased by 2%, 18%, 34%, and 22% respectively, while HCO and MPN fees decreased by 7% and 8%, respectively.

11

Other revenues consisted of revenues derived primarily from network claims repricing services, lien representation services, legal support services, workers’ compensation carve out revenues and Medicare-set-aside revenues.

HCO

During the three-month periods ended March 31, 2019 and 2018, HCO fee revenues were $370,342 and $399,442 respectively.  The 7% decrease in HCO revenue was primarily attributable to a loss of a customer after the first quarter of 2018 and HCO notifications for a customer being sent out in the second quarter of 2019 instead of the first quarter.

MPN

MPN fee revenue for the three-month periods ended March 31, 2019 and 2018, was $123,865 and $134,644, respectively, a decrease of 8% resulting from fewer claims reported by clients.

Utilization Review

During the three-month periods ended March 31, 2019 and 2018, utilization review revenue was $292,683 and $287,021, respectively.  The increase of 2% in the 2019 period was primarily attributable to a net increase in utilization reviews by existing customers. Utilization review can provide a safeguard against unnecessary and inappropriate medical treatment from the perspective of medical necessity, quality of care, and appropriateness of decision-making.

Medical Bill Review

During the three-month period ended March 31, 2019, medical bill review revenue increased 18% from $114,039 to $134,997 when compared to the same period a year earlier.  This increase was due to an increase in the volume of hospital bills reviewed, partially offset by a decrease in the number of non-hospital bills reviewed for existing customers. Medical bill review involves analyzing medical provider services and equipment billing to ascertain proper reimbursement.  Such services include, but are not limited to, coding review and re-bundling, confirming that the services are customary and reasonable, fee schedule compliance, out-of-network bill review, pharmacy review, and preferred provider organization repricing arrangements.  These services can result in significant network savings. 

Medical Case Management

During the three months ended March 31, 2019 and 2018, medical case management revenue was $781,614 and $582,569, respectively. This increase in medical case management revenue of $199,045 was primarily the result of a net increase in the number and time spent on claims managed with existing customers. Medical case management keeps medical treatment claims progressing to a resolution and assures treatment plans are aligned from a medical perspective. Medical oversight is a collaborative process that assesses plans, implements, coordinates, monitors and evaluates the options and services required to meet an injured worker’s health needs. Medical case managers act as a liaison between the injured worker, claims adjuster, medical providers and attorneys to achieve optimal results for injured workers and employer/clients.

Other

Other fees consist of revenue derived from network access and claims repricing, lien representation, legal support services, Medicare-set-aside and workers’ compensation carve-outs services.  Other fee revenue for three-month periods ended March 31, 2019 and 2018, was $79,937 and $65,594, respectively. The increase of $14,343 was primarily the result of an increase in the number of Medicare-set-asides processed.

Expenses

Total expenses for the three months ended March 31, 2019 and 2018, were $1,346,117 and $1,027,652, respectively.  The increase of $318,465 was primarily due to hiring additional employees in the third quarter of the 2018, along with increases in salaries for existing employees, and general and administrative expenses.

12

Depreciation and Amortization

During the three-month period ended March 31, 2019, we recorded depreciation and amortization expense of $18,884 compared to $16,344 during the comparable 2018 period.  The increase in depreciation was primarily due to adjustments for a prior period.

Consulting Fees

During the three months ended March 31, 2019, consulting fees increased to $79,636 from $78,814 during the three months ended March 31, 2018.   This increase was the result of additional fees paid to a consultant.

Salaries and Wages

During the three-month period ended March 31, 2019, salaries and wages increased 53% to $753,705 compared to $491,478 during the same period in 2018.  This increase was primarily the result of hiring a director of healthcare, several full-time employees, and increases in salaries to retain existing employees. We employed 39 and 33 full-time employees as of March 31, 2019 and 2018, respectively.

Professional Fees

For the three months ended March 31, 2019, we incurred professional fees of $77,965 compared to $77,470 during the three months ended March 31, 2018.  The increase in professional fees was mainly the result of increased fees paid to our medical consultant, which was partially offset by decreased professional fees paid for medical case management services.

Insurance

During the three-month period ended March 31, 2019, we incurred insurance expenses of $73,383, a 9% increase over the same three-month period in 2018.  The increase in insurance expense was primarily attributable to hiring additional employees and covering the costs for their health insurance. We expect current insurance fees to moderately increase over the remaining months of 2019.

Outsource Service Fees

Outsource service fees consist of costs incurred by our subsidiaries in outsourcing general administrative tasks, utilization review, medical bill review and medical case management services, and typically tends to increase and decrease in correspondence with increases and decreases in demand for those services.  We incurred $124,809 and $95,881 in outsource service fees during the three-month periods ended March 2019 and 2018, respectively. The 30% increase was the result of an increase in volume from our customers, that required additional outsource services for Medicare-set-asides, medical case management, medical bill review and utilization review.  We anticipate our outsource service fees will continue to move in correspondingly with the levels of client claims.  

Data Maintenance

During the three-month period ended March 31, 2019 and 2018, data maintenance fees were $10,300 and $32,431, respectively.  The decrease of 68% was primarily the result of recording lower levels of notification fees associated with a customer’s annual renewal during the three-month period ended March 31, 2019 when compared to the same period in 2018.

General and Administrative

During the three-month period ended March 31, 2019, general and administrative expenses increased 23% compared to the three-month period ended March 31, 2018. This increase was primarily attributable to increases in auto expense, bank charges, dues and subscriptions, IT enhancement, licenses and permits, parking, and office supplies. We expect current levels of general and administrative expenses to increase during remaining months of 2019 as we will be replacing old computers and enhancing our IT security.

13

Income from Operations

Total income from operations decreased 21% during the three-month period ended March 31, 2019 when compared to the same period in 2018, as the result of increased expenses due to higher salaries, insurance, outsource service fees, and general and administrative expenses. These increased expenses were only partially offset by the 13% increase in revenue we realized during the same period.

Income Tax Provision

We realized income before taxes of $437,321 and $555,657 during the three-month periods ended March 31, 2019 and 2018, respectively. As a result of the this decrease in income from operations, coupled with the lower corporate income tax rate pursuant to the Tax Cuts and Jobs Act of 2017 (the “TCJA”) we realized a 21% decrease in our income tax provision. 

Net Income

During the three-month period ended March 31, 2019, total net income was $314,563 compared $399,681 when to the same period in 2018.  As discussed above, this decrease in net income was primarily due to higher expenses resulting from hiring additional employees, insurance expenses, outsource service fees, and general administrative expenses.

Liquidity and Capital Resources

As of March 31, 2019, we had cash on hand of $7,368,174 compared to $7,072,507 at December 31, 2018.  The $295,667 increase was primarily the result of net cash provided by our operating activities, partially offset by cash used in investing activities. Net cash provided by our operating activities was the result of realizing net income coupled with increases in accounts payable, accrued expenses, and income tax payable and decreases in credit card payables and deferred rent expense and an increase in accounts receivable. We used $2,284 in investing activities to purchase computers, furniture and equipment.  Barring a significant downturn in the economy or the loss of major customers, we believe that cash on hand and anticipated revenues from operations will be sufficient to cover our operating expenses over the next twelve months.

We currently have planned certain capital expenditures during 2019, to expand our IT capabilities and equipment.  We believe we have adequate capital on hand to cover these expenditures and do not anticipate this will require us to seek outside sources of funding.  

We continue to investigate potential opportunities to expand our business either through the creation of new business lines or the acquisition of existing businesses.  We are also looking to expand our business into the insurance industry during 2019 but have not identified any suitable merger or acquisition candidates or opportunities at the current time.  We anticipate an expansion or acquisition of this sort may require greater capital resources than we currently possess.  Should we need additional capital resources, we could seek to obtain such through debt and/or equity financing.  We do not currently possess an institutional source of financing and there is no assurance that we could be successful in obtaining equity or debt financing when needed on favorable terms, or at all.  We could also use shares of our capital stock as consideration for a business acquisition transaction.

Cash Flow

During the three months ended March 31, 2019, cash was primarily used to fund operations. We had a net increase in cash of $295,667 during the three months ended March 31, 2019, compared to a net increase of $890,610 during the three months ended March 31, 2018.  See below for additional information.

	For the three months ended March 31,
	2019 (unaudited)			2018 (unaudited)
Net cash provided by operating activities	$	297,951		$	893,598
Net cash used in investing activities		(2,284	)		(2,988	)
Net cash used in financing activities		-			-
Net increase in cash	$	295,667		$	890,610

14

During the three months ended March 31, 2019 and 2018, net cash provided by operating activities was $297,951 and $893,598, respectively.

As discussed herein, we realized net income of $314,563 during the three months ended March 31, 2019, compared to net income of $399,681 during the three months ended March 31, 2018. The decrease of $595,647 in cash flow from operating activities was primarily the result of decreases in net income, prepaid expenses, deferred rent expense, credit card payables and unearned revenues and increase in accounts receivable, partially offset by increases in accounts receivables and depreciation and amortization.

Net cash used in investing activities was $2,284 and $2,988 during the three-month periods ended March 31, 2019 and 2018, respectively.  Net cash used in investing activities was lower by $704 during the three-month period ended March 31, 2019 when compared to March 31, 2018, because of lower expenditures for computers, furniture, and equipment.

Off-Balance Sheet Financing Arrangements

As of March 31, 2019, we had no off-balance sheet financing arrangements.

Inflation

We experience pricing pressures in the form of competitive prices.  We are also impacted by rising costs for certain inflation-sensitive operating expenses such as labor and employee benefits and facility leases.  However, we generally do not believe these impacts are material to our revenues or net income.

Critical Accounting Policies and Estimates

See Note 1 to our condensed consolidated financial statements included elsewhere in this report.

15

Item 3.     Quantitative and Qualitative Disclosure about Market Risk

This information is not required for smaller reporting companies.

Item 4.     Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, which are controls and other procedures that are designed to provide reasonable assurance that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.  Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

Our management, under the supervision and with the participation of our principal executive officer and principal financial officer, conducted an evaluation the effectiveness of our disclosure controls and procedures as of the end of the period covered by this quarterly report on Form 10-Q.  Based on the evaluation of our disclosure controls and procedures as of March 31, 2019, the end of the period covered by this report, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended March 31, 2019, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

16

PART II.   OTHER INFORMATION

Item 1A. Risk Factors

Management does not believe there have been any material changes to the risk factors listed in Part I, “Item 1A, Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2018.  These risk factors should be carefully considered with the information provided elsewhere in this report, which could materially adversely affect our business, financial condition or results of operations.

Item 6.     Exhibits

Exhibits.  The following exhibits are filed or furnished, as applicable, as part of this report:

Exhibit Number	Title of Document
Exhibit 31.1	Certification of Principal Executive Officer pursuant to Rule 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 31.2	Certification of Principal Financial Officer pursuant to Rule 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 32.1	Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Exhibit 101	The following materials from Pacific Health Care Organization, Inc.’s Quarterly Report on Form 10-Q for the period ended March 31, 2019, formatted in XBRL (eXtensible Business Reporting Language): (i) the Unaudited Condensed Consolidated Balance Sheets, (ii) the Unaudited Condensed Consolidated Statements of Operations, (iii) the Unaudited Condensed Consolidated Statements of Cash Flows, and (iv) Notes to the Unaudited Condensed Consolidated Financial Statements.

17

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		PACIFIC HEALTH CARE ORGANIZATION, INC.
Date:	May 20, 2019	/s/ Tom Kubota
		Tom Kubota Chief Executive Officer

Date:	May 20, 2019	/s/ Fred Odaka
		Fred Odaka Chief Financial Officer

18

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Tom Kubota, certify that:

1)  I have reviewed this quarterly report on Form 10-Q of Pacific Health Care Organization, Inc.

2)  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)  The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

(a) Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controls over financial reporting; and

5)  The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 20, 2019	/s/ Tom Kubota
	Tom Kubota
	Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Fred Odaka, certify that:

1)  I have reviewed this quarterly report on Form 10-Q of Pacific Health Care Organization, Inc.

2)  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

(a) Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controls over financial reporting; and

5)  The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 20, 2019	/s/ Fred Odaka
	Fred Odaka
	Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Pacific Health Care Organization, Inc. (the “Company”) for the period ended March 31, 2019 as filed with the Securities and Exchange Commission (the “Report”), the undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of their knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: May 20, 2019	/s/ Tom Kubota
	Tom Kubota
	Chief Executive Officer

Date: May 20, 2019	/s/ Fred Odaka
	Fred Odaka
	Chief Financial Officer

This certification is not deemed filed with the Securities and Exchange Commission and is not incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this Report), irrespective of any general incorporation language contained in such filing.

XML

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2019	May 20, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	PACIFIC HEALTH CARE ORGANIZATION INC
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		3,200,000
Amendment Flag	false
Entity Central Index Key	0001138476
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Ex Transition Period	false

XML

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Current Assets
Cash	$ 7,368,174	$ 7,072,507
Accounts receivable, net of allowance of $28,442 and $28,442	1,100,867	940,426
Deferred tax assets	63,465	63,465
Prepaid income tax	73,959	73,959
Receivable – Other	23,715	23,715
Prepaid expenses	186,545	163,255
Total current assets	8,816,725	8,337,327
Property and Equipment, net
Computer equipment	407,503	405,219
Furniture and fixtures	215,960	215,960
Office equipment	9,556	9,556
Total property and equipment	633,019	630,735
Less: accumulated depreciation and amortization	(507,992)	(489,108)
Net property and equipment	125,027	141,627
Operating lease right-of-use asset, net	719,861	0
Other assets	26,788	26,788
Total assets	9,688,401	8,505,742
Current Liabilities
Accounts payable	70,672	63,724
Accrued expenses	272,092	248,455
Credit card payable	1,444	3,146
Income tax payable	122,859	100
Deferred rent expense	22,707	26,114
Dividend payable	37,000	37,000
Operating lease liabilities, current portion	247,472	0
Unearned revenue	45,448	45,448
Total current liabilities	819,694	423,987
Long Term Liabilities
Operating lease liabilities, long-term portion	472,389	0
Total Liabilities	1,292,083	423,987
Commitments and Contingencies
Stockholders’ Equity
Preferred stock; 5,000,000 shares authorized at $0.001 par value of which 10,000 shares designated as Series A preferred and 4,000 shares issued and outstanding at March 31, 2019 and December 31, 2018	4	4
Common stock, $0.001 par value, 200,000,000 shares authorized, 3,200,000 shares issued and outstanding at March 31, 2019 and December 31, 2018	3,200	3,200
Additional paid-in capital	425,669	425,669
Retained earnings	7,967,445	7,652,882
Total stockholders’ equity	8,396,318	8,081,755
Total liabilities and stockholders’ equity	$ 9,688,401	$ 8,505,742

XML

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Accounts receivable, allowance (in Dollars)	$ 28,442	$ 28,442
Preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	4,000	4,000
Preferred stock, shares outstanding	4,000	4,000
Common stock par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	3,200,000	3,200,000
Common stock, outstanding	3,200,000	3,200,000
Series A Preferred Stock [Member]
Preferred stock, shares authorized	10,000	10,000

XML

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenues:
Revenues	$ 1,783,438	$ 1,583,309
Expenses:
Depreciation and amortization	18,884	16,344
Consulting fees	79,635	78,814
Salaries and wages	753,705	491,478
Professional fees	77,965	77,470
Insurance	73,383	67,029
Outsource service fees	124,809	95,881
Data maintenance	10,300	32,431
General and administrative	207,435	168,205
Total expenses	1,346,116	1,027,652
Income from operations	437,322	555,657
Other expense
Interest expense	0	0
Total other expense	0	0
Income before taxes	437,322	555,657
Income tax provision	(122,759)	(155,976)
Net income	$ 314,563	$ 399,681
Earnings per share amount (in Dollars per share)	$ 0.10	$ 0.12
Weighted average common shares outstanding (in Shares)	3,200,000	3,200,000
Fully diluted earnings per share:
Earnings per share amount (in Dollars per share)	$ 0.09	$ 0.11
Fully diluted common shares outstanding (in Shares)	3,544,000	3,544,000
HCO Fees [Member]
Revenues:
Revenues	$ 370,342	$ 399,442
MPN Fees [Member]
Revenues:
Revenues	123,865	134,644
Utilization review [Member]
Revenues:
Revenues	292,683	287,021
Medical bill review [Member]
Revenues:
Revenues	134,997	114,039
Medical case management [Member]
Revenues:
Revenues	781,614	582,569
Other Revenues [Member]
Revenues:
Revenues	$ 79,937	$ 65,594

XML

Condensed Consolidated Statements of Stockholders' Equity - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balances at Dec. 31, 2017	$ 4	$ 3,200	$ 425,669	$ 6,293,105	$ 6,721,978
Net Income				399,681	399,681
Balances at Mar. 31, 2018	4	3,200	425,669	6,692,786	7,121,659
Balances at Dec. 31, 2018	4	3,200	425,669	7,652,882	8,081,755
Net Income				314,563	314,563
Balances at Mar. 31, 2019	$ 4	$ 3,200	$ 425,669	$ 7,967,445	$ 8,396,318

XML

Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income	$ 314,563	$ 399,681
Adjustments to reconcile net income to net cash:
Depreciation and amortization	18,884	16,344
Changes in operating assets and liabilities
(Increase) decrease in accounts receivable	(160,441)	377,919
(Increase) in prepaid expenses	(23,290)	(3,875)
Increase (decrease) in accounts payable	6,948	(47,225)
(Decrease) in deferred rent expense	(3,407)	(1,142)
(Decrease) in credit card payables	(1,702)	0
Increase (decrease) in accrued expenses	23,637	(4,412)
Increase in income tax payable	122,759	155,976
Decrease in unearned revenue	0	332
Net cash provided in operating activities	297,951	893,598
Cash flows from investing activities:
Purchase of furniture and office equipment	(2,284)	(2,988)
Net cash used in investing activities	(2,284)	(2,988)
Cash flows from financing activities:
Net cash used in financing activities	0	0
Increase in cash	295,667	890,610
Cash at beginning of period	7,072,507	5,815,071
Cash at end of period	7,368,174	6,705,681
Cash paid for:
Interest	0	0
Income taxes paid	0	0
Non-cash investing and financing activities
Initial recognition of operating lease right of use asset and operating lease liabilities	$ 719,861	$ 0

XML

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”) and in accordance with accounting principles generally accepted in the United States (“GAAP”).  Certain information and footnote disclosures normally included in consolidated financial statements have been condensed or omitted in accordance with GAAP rules and regulations.  The information furnished in these interim condensed consolidated financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect both the recorded values of assets and liabilities at the date of the condensed consolidated financial statements and the revenues recognized and expenses incurred during the reporting period. These estimates and assumptions affect the Company’s recognition of deferred expenses, bad debts, income taxes, the carrying value of its long-lived assets and its provision for certain contingencies. The reasonableness of these estimates and assumptions is evaluated continually based on a combination of historical information and other information that comes to the Company’s attention that may vary its outlook for the future. While management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed consolidated financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its annual report on Form 10-K for the year ended December 31, 2018.  Operating results for the three months ended March 31, 2019, are not necessarily indicative of the results to be expected for the year ending December 31, 2019.

Principles of Consolidation — The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  Intercompany transactions and balances have been eliminated in consolidation.

Basis of Accounting — The Company uses the accrual method of accounting.

Revenue Recognition — The Company follows the guidance of Accounting Standards Codification (ASC) 606, “Revenue from Contracts with Customers (Topic 606).”

Topic 606 creates a five-step model to recognize revenue which includes (i) identifying the contract with the customer, (ii) identifying the performance obligations in the contract, (iii) determining the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocating the transaction price to the respective performance obligations in the contract, and (v) recognizing revenue when (or as) the Company satisfies the performance obligation. 

The Company derives its revenue from the sale of managed care, bill review, utilization review and medical case management services. These services are billed individually as separate components to our customers. These fees include monthly administration fees, claim network fees, legal support fees, Medicare set-aside fees, lien service fees, workers’ compensation carve-outs, flat rate fees or hourly fees depending on the agreement with the client.

The Company enters into arrangements for bundled managed care which includes various units of accounting such as network solutions and patient management, including managed care. Such elements are considered separate units of accounting due to each element having value to the customer on a stand-alone basis and are billed separately. The selling price for each unit of accounting is determined using the contract price. When the Company’s customers purchase several products the pricing of the products sold is generally the same as if the products were sold on an individual basis. Revenue is recognized as the work is performed in accordance with the Company’s customer contracts. Based upon the nature of the Company’s products, bundled managed care elements are generally delivered in the same accounting period. The Company recognizes revenue for patient management services ratably over the life of the customer contract. Based upon prior experience in managed care, the Company estimates the deferral amount from when the customer’s claim is received to when the customer contract expires. Advance payments from subscribers and billings made in advance are recorded on the balance sheet as deferred revenue.

Accounts Receivables and Bad Debt Allowance – In the normal course of business the Company extends credit to its customers on a short-term basis.  Although the credit risk associated with these customers is minimal, the Company routinely reviews its accounts receivable balances and makes provisions for doubtful accounts.  The Company ages its receivables by date of invoice.  Management reviews bad debt reserves quarterly and reserves specific accounts as warranted or sets up a general reserve based on amounts over 90 days past due.  When an account is deemed uncollectible, the Company charges off the receivable against the bad debt reserve.  A considerable amount of judgment is required in assessing the realization of these receivables including the current creditworthiness of each customer and related aging of the past-due balances, including any billing disputes.  In order to assess the collectability of these receivables, the Company performs ongoing credit evaluations of its customers’ financial condition. Through these evaluations, the Company may become aware of a situation where a customer may not be able to meet its financial obligations due to deterioration of its financial viability, credit rating or bankruptcy.  The allowance for doubtful accounts is based on the best information available to the Company and is reevaluated and adjusted as additional information is received.  We evaluate the allowance based on historical write-off experience, the size of the individual customer balances, past-due amounts and the overall national economy.  At March 31, 2019 and December 31, 2018, bad debt reserves of $28,442 and $28,442, respectively, was a general reserve for certain balances over 90 days past due and for accounts that are potentially uncollectible.

The percentages of the amounts due from major customers to total accounts receivable as of March 31, 2019 and December 31, 2018, are as follows:

	3/31/2019			12/31/2018
Customer A		31	%		27	%
Customer B		3	%		10	%
Customer C		10	%		9	%

Significant Customers - We provide services to insurers, third party administrators, self-administered employers, municipalities and other industries.  We are able to provide our full range of services to virtually any size employer in the state of California.  We are also able to provide utilization review, medical bill review and medical case management services outside the state of California. 

During the period ended March 31, 2019 and 2018, we had three customers that accounted for more than 10% of our total sales.  The following table sets forth details regarding the percentage of total sales attributable to our significant customers in the past two years:

	3/31/2019			3/31/2018
Customer A		28	%		32	%
Customer B		13	%		11	%
Customer C		10	%		6	%

Leases - Prior to January 1, 2019, the Company accounted for leases under ASC 840, Accounting for Leases. Effective January 1, 2019, the Company adopted the guidance of ASC 842, Leases, which requires an entity to recognize a right-of-use asset and a lease liability for virtually all leases. The Company adopted ASC 842 using a modified retrospective approach. As a result, the comparative financial information has not been updated and the required disclosures prior to the date of adoption have not been updated and continue to be reported under the accounting standards in effect for those periods. The adoption of ASC 842 on January 1, 2019 resulted in the recognition of operating lease right-of-use assets of $719,861, lease liabilities for operating leases of $719,861, and a zero cumulative-effect adjustment to accumulated deficit. The Company elected to exclude from its balance sheets recognition of leases having a term of 12 months or less (“short-term leases”). Lease expense is recognized on a straight-line basis over the lease term. See Note 2 for further information regarding the impact of the adoption of ASC 842 on the Company’s financial statements.

XML

NOTE 2- OPERATING LEASES

3 Months Ended

Mar. 31, 2019

Disclosure Text Block [Abstract]

Lessee, Operating Leases [Text Block]

NOTE 2- OPERATING LEASES

In July 2015, the Company entered a 79-month lease to lease approximately 9,439 square feet of office space that commenced in September 2015. This office space serves as the Company’s principal executive offices, as well as, the principal offices of our operating subsidiaries. In March 2017, the Company entered a 39-month operating lease for an office copy machine with scanner with monthly payment at $1,723, commencing in April 2017.

Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Generally the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The operating lease ROU asset includes any lease payments made and excludes lease incentives.

The components of lease expense and supplemental cash flow information related to leases for the period are as follows:

	Three Months Ended March 31, 2019
Lease Cost
Operating lease cost (included in general and administrative in the Company’s condensed consolidated statement of operations)	$	66,230
Other Information
Cash paid for amounts included in the measurement of lease liabilities for the first quarter 2019	$	66,230
Weighted average remaining lease term – operating leases (in years)	3 years
Average discount rate – operating leases		5.75	%

The supplemental balance sheet information related to leases for the period is as follows:

	At March 31, 2019
Operating leases
Long-term right-of-use assets	$	719,861
Short-term operating lease liabilities	$	247,472
Long-term operating lease liabilities		472,389
Total operating lease liabilities	$	719,861

Maturities of the Company’s lease liabilities are as follows:

Year Ending	Operating Leases
2019 (remaining 9 months)	$	191,449
2020		281,803
2021		257,024
2022		71,359
Total lease payments		801,635
Less: Imputed interest/present value discount		(81,774	)
Present value of lease liabilities	$	719,861

Lease expenses were $66,230 and $66,230 during the three months ended March 31, 2019 and 2018, respectively.

XML

NOTE 3 - SUBSEQUENT EVENTS

3 Months Ended

Mar. 31, 2019

Subsequent Events [Abstract]

Subsequent Events [Text Block]

NOTE 3 - SUBSEQUENT EVENTS

In accordance with ASC 855-10 Company management reviewed all material events through the date of issuance and there are no material subsequent events to report.

XML

Accounting Policies, by Policy (Policies)

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Consolidation, Policy [Policy Text Block]

Principles of Consolidation — The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  Intercompany transactions and balances have been eliminated in consolidation.

Basis of Accounting, Policy [Policy Text Block]

Basis of Accounting — The Company uses the accrual method of accounting.

Revenue [Policy Text Block]

Revenue Recognition — The Company follows the guidance of Accounting Standards Codification (ASC) 606, “Revenue from Contracts with Customers (Topic 606).”

Topic 606 creates a five-step model to recognize revenue which includes (i) identifying the contract with the customer, (ii) identifying the performance obligations in the contract, (iii) determining the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocating the transaction price to the respective performance obligations in the contract, and (v) recognizing revenue when (or as) the Company satisfies the performance obligation. 

The Company derives its revenue from the sale of managed care, bill review, utilization review and medical case management services. These services are billed individually as separate components to our customers. These fees include monthly administration fees, claim network fees, legal support fees, Medicare set-aside fees, lien service fees, workers’ compensation carve-outs, flat rate fees or hourly fees depending on the agreement with the client.

The Company enters into arrangements for bundled managed care which includes various units of accounting such as network solutions and patient management, including managed care. Such elements are considered separate units of accounting due to each element having value to the customer on a stand-alone basis and are billed separately. The selling price for each unit of accounting is determined using the contract price. When the Company’s customers purchase several products the pricing of the products sold is generally the same as if the products were sold on an individual basis. Revenue is recognized as the work is performed in accordance with the Company’s customer contracts. Based upon the nature of the Company’s products, bundled managed care elements are generally delivered in the same accounting period. The Company recognizes revenue for patient management services ratably over the life of the customer contract. Based upon prior experience in managed care, the Company estimates the deferral amount from when the customer’s claim is received to when the customer contract expires. Advance payments from subscribers and billings made in advance are recorded on the balance sheet as deferred revenue.

Receivable [Policy Text Block]

Accounts Receivables and Bad Debt Allowance – In the normal course of business the Company extends credit to its customers on a short-term basis.  Although the credit risk associated with these customers is minimal, the Company routinely reviews its accounts receivable balances and makes provisions for doubtful accounts.  The Company ages its receivables by date of invoice.  Management reviews bad debt reserves quarterly and reserves specific accounts as warranted or sets up a general reserve based on amounts over 90 days past due.  When an account is deemed uncollectible, the Company charges off the receivable against the bad debt reserve.  A considerable amount of judgment is required in assessing the realization of these receivables including the current creditworthiness of each customer and related aging of the past-due balances, including any billing disputes.  In order to assess the collectability of these receivables, the Company performs ongoing credit evaluations of its customers’ financial condition. Through these evaluations, the Company may become aware of a situation where a customer may not be able to meet its financial obligations due to deterioration of its financial viability, credit rating or bankruptcy.  The allowance for doubtful accounts is based on the best information available to the Company and is reevaluated and adjusted as additional information is received.  We evaluate the allowance based on historical write-off experience, the size of the individual customer balances, past-due amounts and the overall national economy.  At March 31, 2019 and December 31, 2018, bad debt reserves of $28,442 and $28,442, respectively, was a general reserve for certain balances over 90 days past due and for accounts that are potentially uncollectible.

The percentages of the amounts due from major customers to total accounts receivable as of March 31, 2019 and December 31, 2018, are as follows:

	3/31/2019			12/31/2018
Customer A		31	%		27	%
Customer B		3	%		10	%
Customer C		10	%		9	%

Concentration Risk, Customer Risk, Policy [Policy Text Block]

Significant Customers - We provide services to insurers, third party administrators, self-administered employers, municipalities and other industries.  We are able to provide our full range of services to virtually any size employer in the state of California.  We are also able to provide utilization review, medical bill review and medical case management services outside the state of California. 

During the period ended March 31, 2019 and 2018, we had three customers that accounted for more than 10% of our total sales.  The following table sets forth details regarding the percentage of total sales attributable to our significant customers in the past two years:

	3/31/2019			3/31/2018
Customer A		28	%		32	%
Customer B		13	%		11	%
Customer C		10	%		6	%

Lessee, Leases [Policy Text Block]

Leases - Prior to January 1, 2019, the Company accounted for leases under ASC 840, Accounting for Leases. Effective January 1, 2019, the Company adopted the guidance of ASC 842, Leases, which requires an entity to recognize a right-of-use asset and a lease liability for virtually all leases. The Company adopted ASC 842 using a modified retrospective approach. As a result, the comparative financial information has not been updated and the required disclosures prior to the date of adoption have not been updated and continue to be reported under the accounting standards in effect for those periods. The adoption of ASC 842 on January 1, 2019 resulted in the recognition of operating lease right-of-use assets of $719,861, lease liabilities for operating leases of $719,861, and a zero cumulative-effect adjustment to accumulated deficit. The Company elected to exclude from its balance sheets recognition of leases having a term of 12 months or less (“short-term leases”). Lease expense is recognized on a straight-line basis over the lease term. See Note 2 for further information regarding the impact of the adoption of ASC 842 on the Company’s financial statements.

XML

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION (Tables)

3 Months Ended

Mar. 31, 2019

Credit Concentration Risk [Member]

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION (Tables) [Line Items]

Schedules of Concentration of Risk, by Risk Factor [Table Text Block]

The percentages of the amounts due from major customers to total accounts receivable as of March 31, 2019 and December 31, 2018, are as follows:

	3/31/2019			12/31/2018
Customer A		31	%		27	%
Customer B		3	%		10	%
Customer C		10	%		9	%

Customer Concentration Risk [Member]

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION (Tables) [Line Items]

Schedules of Concentration of Risk, by Risk Factor [Table Text Block]

During the period ended March 31, 2019 and 2018, we had three customers that accounted for more than 10% of our total sales. The following table sets forth details regarding the percentage of total sales attributable to our significant customers in the past two years:

	3/31/2019			3/31/2018
Customer A		28	%		32	%
Customer B		13	%		11	%
Customer C		10	%		6	%

XML

NOTE 2- OPERATING LEASES (Tables)

3 Months Ended

Mar. 31, 2019

Disclosure Text Block [Abstract]

Lease, Cost [Table Text Block]

The components of lease expense and supplemental cash flow information related to leases for the period are as follows:

	Three Months Ended March 31, 2019
Lease Cost
Operating lease cost (included in general and administrative in the Company’s condensed consolidated statement of operations)	$	66,230
Other Information
Cash paid for amounts included in the measurement of lease liabilities for the first quarter 2019	$	66,230
Weighted average remaining lease term – operating leases (in years)	3 years
Average discount rate – operating leases		5.75	%

Lessee, Operating Lease, Disclosure [Table Text Block]

The supplemental balance sheet information related to leases for the period is as follows:

	At March 31, 2019
Operating leases
Long-term right-of-use assets	$	719,861
Short-term operating lease liabilities	$	247,472
Long-term operating lease liabilities		472,389
Total operating lease liabilities	$	719,861

Lessee, Operating Lease, Liability, Maturity [Table Text Block]

Maturities of the Company’s lease liabilities are as follows:

Year Ending	Operating Leases
2019 (remaining 9 months)	$	191,449
2020		281,803
2021		257,024
2022		71,359
Total lease payments		801,635
Less: Imputed interest/present value discount		(81,774	)
Present value of lease liabilities	$	719,861

XML

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)	3 Months Ended
	Mar. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION (Details) [Line Items]
Accounts Receivable, Allowance for Credit Loss	$ 28,442	$ 28,442
Operating Lease, Right-of-Use Asset	719,861	$ 0
Operating Lease, Liability	719,861
Cumulative Effect on Retained Earnings, Net of Tax	$ 0
Revenue Benchmark [Member] | Customer Concentration Risk [Member]
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION (Details) [Line Items]
Number of Customers	3

XML

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION (Details) - Schedules of Credit Concentration Risk - Credit Concentration Risk [Member] - Accounts Receivable [Member]	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Customer A [Member]
Concentration Risk [Line Items]
Credit Concentration Risk, Percentage	31.00%	27.00%
Customer B [Member]
Concentration Risk [Line Items]
Credit Concentration Risk, Percentage	3.00%	10.00%
Customer C [Member]
Concentration Risk [Line Items]
Credit Concentration Risk, Percentage	10.00%	9.00%

XML

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION (Details) - Schedules of Customer Concentration Risk - Customer Concentration Risk [Member] - Revenue Benchmark [Member]	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Customer A [Member]
Concentration Risk [Line Items]
Customer Concentration Risk	28.00%	32.00%
Customer B [Member]
Concentration Risk [Line Items]
Customer Concentration Risk	13.00%	11.00%
Customer C [Member]
Concentration Risk [Line Items]
Customer Concentration Risk	10.00%	6.00%

XML

NOTE 2- OPERATING LEASES (Details)		3 Months Ended
	Mar. 31, 2017 USD ($)	Mar. 31, 2019 USD ($)	Mar. 31, 2018 USD ($)	Jul. 31, 2015 ft²
Disclosure Text Block [Abstract]
Lessee, Operating Lease, Term of Contract	39 months			79 months
Area of Real Estate Property (in Square Feet) | ft²				9,439
Operating Leases, Rent Expense, Minimum Rentals	$ 1,723
Operating Leases, Rent Expense		$ 66,230	$ 66,230

XML

NOTE 2- OPERATING LEASES (Details) - Lease, Cost	3 Months Ended
	Mar. 31, 2019 USD ($)
Lease, Cost [Abstract]
Operating lease cost (included in general and administrative in the Company’s condensed consolidated statement of operations)	$ 66,230
Cash paid for amounts included in the measurement of lease liabilities for the first quarter 2019	$ 66,230
Weighted average remaining lease term – operating leases (in years)	3 years
Average discount rate – operating leases	5.75%

XML

NOTE 2- OPERATING LEASES (Details) - Lessee, Operating Lease, Disclosure - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Lessee, Operating Lease, Disclosure [Abstract]
Long-term right-of-use assets	$ 719,861	$ 0
Short-term operating lease liabilities	247,472	0
Long-term operating lease liabilities	472,389	$ 0
Total operating lease liabilities	$ 719,861

XML

NOTE 2- OPERATING LEASES (Details) - Lessee, Operating Lease, Liability, Maturity	Mar. 31, 2019 USD ($)
Lessee, Operating Lease, Liability, Maturity [Abstract]
2019 (remaining 9 months)	$ 191,449
2020	281,803
2021	257,024
2022	71,359
Total lease payments	801,635
Less: Imputed interest/present value discount	(81,774)
Present value of lease liabilities	$ 719,861